Editorial: Tumor microenvironment (TME) and tumor immune microenvironment (TIME): New perspectives for prognosis and therapy

Rodrigo Nalio Ramos; Mariane Tami Amano; Adriana Franco Paes Leme; Jay Willian Fox; Ana Karina de Oliveira

doi:10.3389/fcell.2022.971275

Editorial: Tumor microenvironment (TME) and tumor immune microenvironment (TIME): New perspectives for prognosis and therapy

Front Cell Dev Biol. 2022 Aug 22:10:971275. doi: 10.3389/fcell.2022.971275. eCollection 2022.

Authors

Rodrigo Nalio Ramos¹, Mariane Tami Amano², Adriana Franco Paes Leme³, Jay Willian Fox⁴, Ana Karina de Oliveira⁵

Affiliations

¹ Departament of Hematology and Cell Therapy, Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), D'Or Institute for Research and Education (IDOR), Hospital Das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
² Hospital Sirio Libanes, São Paulo, Brazil.
³ Brazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, Brazil.
⁴ Department of Microbiology, Immunology and Cancer Biology, Office of Research Core Administration (ORCA), University of Virginia School of Medicine, Charlottesville, VA, United States.
⁵ Department of Pathology, University of Virginia School of Medicine, Spatial Biology Core (SBC) Facility, Charlottesville, VA, United States.

No abstract available

Keywords: immune checkpoint blockade; immune therapeutics; prognosis; tumor immune microenvioronment; tumor stroma cross-talk; tumormicroenvironment.

Publication types

Editorial